Ray Paxton

602 total citations
8 papers, 508 citations indexed

About

Ray Paxton is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Ray Paxton has authored 8 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Oncology and 1 paper in Epidemiology. Recurrent topics in Ray Paxton's work include Immune Cell Function and Interaction (4 papers), T-cell and Retrovirus Studies (3 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Ray Paxton is often cited by papers focused on Immune Cell Function and Interaction (4 papers), T-cell and Retrovirus Studies (3 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Ray Paxton collaborates with scholars based in Canada, United States and Israel. Ray Paxton's co-authors include Subhashini Srinivasan, Kenneth H. Grabstein, William C. Fanslow, Marylou G. Gibson, Melanie K. Spriggs, Richard J. Armitage, Susan Quinn DeJoy, Michael M. Wick, S.S. Kerwar and Robert Jeyaseelan and has published in prestigious journals such as Journal of Biological Chemistry, Seminars in Immunology and Cytokine.

In The Last Decade

Ray Paxton

8 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ray Paxton Canada 6 381 153 99 69 49 8 508
Anna K. Murray United Kingdom 14 226 0.6× 162 1.1× 171 1.7× 50 0.7× 35 0.7× 23 446
Sally R. Masters United States 7 627 1.6× 88 0.6× 87 0.9× 49 0.7× 47 1.0× 8 755
Machiko Atsuta Japan 8 788 2.1× 167 1.1× 125 1.3× 59 0.9× 36 0.7× 9 919
Alfons J. van den Eertwegh Netherlands 12 545 1.4× 257 1.7× 118 1.2× 53 0.8× 88 1.8× 24 729
Yun Hee Cho United States 7 436 1.1× 100 0.7× 123 1.2× 47 0.7× 45 0.9× 9 581
Nakami Hirayama Japan 7 432 1.1× 242 1.6× 143 1.4× 31 0.4× 97 2.0× 9 631
Satoru Ono Japan 7 406 1.1× 113 0.7× 161 1.6× 62 0.9× 33 0.7× 7 533
Montserrat Casamayor‐Palleja United Kingdom 12 691 1.8× 125 0.8× 208 2.1× 40 0.6× 66 1.3× 14 883
C Jemma Italy 12 282 0.7× 157 1.0× 67 0.7× 56 0.8× 32 0.7× 17 406
Gijs M.W. van Schijndel Netherlands 11 734 1.9× 168 1.1× 176 1.8× 54 0.8× 116 2.4× 15 885

Countries citing papers authored by Ray Paxton

Since Specialization
Citations

This map shows the geographic impact of Ray Paxton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray Paxton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray Paxton more than expected).

Fields of papers citing papers by Ray Paxton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ray Paxton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray Paxton. The network helps show where Ray Paxton may publish in the future.

Co-authorship network of co-authors of Ray Paxton

This figure shows the co-authorship network connecting the top 25 collaborators of Ray Paxton. A scholar is included among the top collaborators of Ray Paxton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ray Paxton. Ray Paxton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Cosman, David, Satoru Kumaki, Minoo Ahdieh, et al.. (2007). Interleukin 15 and Its Receptor. Novartis Foundation symposium. 195. 221–233. 5 indexed citations
2.
Black, Roy A., John R. Doedens, Rajeev Mahimkar, et al.. (2003). Substrate specificity and inducibility of TACE (tumour necrosis factor α-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activity. Biochemical Society Symposia. 70(70). 39–52. 62 indexed citations
3.
Tobi, Martin, Paul Rozen, M Baratz, et al.. (1998). Shared Tumor Antigens in Colorectal Carcinoma and Neuroendocrine Tumors. Cancer Detection and Prevention. 22(2). 147–152. 3 indexed citations
4.
Pettit, Dean K., Timothy P. Bonnert, June Eisenman, et al.. (1997). Structure-Function Studies of Interleukin 15 using Site-specific Mutagenesis, Polyethylene Glycol Conjugation, and Homology Modeling. Journal of Biological Chemistry. 272(4). 2312–2318. 94 indexed citations
5.
Munger, William E., Susan Quinn DeJoy, Robert Jeyaseelan, et al.. (1995). Studies Evaluating the Antitumor Activity and Toxicity of Interleukin-15, a New T Cell Growth Factor: Comparison with Interleukin-2. Cellular Immunology. 165(2). 289–293. 177 indexed citations
6.
Fanslow, William C., Subhashini Srinivasan, Ray Paxton, et al.. (1994). Structural characteristics of CD40 ligand that determine biological function. Seminars in Immunology. 6(5). 267–278. 144 indexed citations
7.
Giri, Judith G., Kenneth H. Grabstein, June Eisenman, et al.. (1994). A novel T cell factor IL-15, shares both the beta and gamma subunits of the IL-2 receptor. Cytokine. 6(5). 553–553. 7 indexed citations
8.
Paxton, Ray, Grant Williams, & J. S. Macdonald. (1975). Role of lymphography in carcinoma of the prostate.. BMJ. 1(5950). 120–122. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026